This inventor holds 1 USPTO granted patent. Top assignees: Dic Corporation, Kawamura Institute of Chemical Research. Active years: 2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 2016
Title: Kazuomi Kubota: Innovator in Antithrombotic Coating Technology
Introduction
Kazuomi Kubota is a notable inventor based in Sakura, Japan. He has made significant contributions to the field of medical technology, particularly in the development of innovative coating agents for medical instruments. His work focuses on enhancing the performance and safety of medical devices.
Latest Patents
Kazuomi Kubota holds a patent for a block copolymer and an antithrombotic coating agent. The objective of this invention is to provide a copolymer that exhibits excellent coating formation ability and adhesive properties to a substrate while minimizing protein adsorption. This antithrombotic coating agent demonstrates superior properties compared to conventional agents, making it a valuable advancement in medical technology. The block copolymer includes a polymer (A) containing a (meth)acrylic ester monomer and a polymer (B) containing a (meth)acrylamide monomer, ensuring high adhesive properties and effective coating formation.
Career Highlights
Throughout his career, Kazuomi Kubota has worked with reputable organizations, including the Kawamura Institute of Chemical Research and Dic Corporation. His experience in these institutions has contributed to his expertise in polymer chemistry and medical applications.
Collaborations
Kazuomi has collaborated with notable colleagues such as Kazutoshi Haraguchi and Tooru Takehisa. These partnerships have fostered innovation and development in the field of medical coatings.
Conclusion
Kazuomi Kubota's contributions to the field of antithrombotic coatings represent a significant advancement in medical technology. His innovative approach and dedication to improving medical instruments have the potential to enhance patient safety and treatment outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile